Literature DB >> 15084973

Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection.

Akimasa Nakao1, Shin Takeda, Mitsuru Sakai, Tetsuya Kaneko, Soichiro Inoue, Hiroyuki Sugimoto, Naohito Kanazumi.   

Abstract

OBJECTIVES: This clinical study was carried out to clarify the indications for extended radical resection for pancreatic carcinoma.
METHODS: From July 1981 to September 2003, 250 of 391 (63.9%) patients with pancreatic carcinoma underwent tumor resection in our department. Portal vein resection was performed in 171 of these 250 (68.4%) resected cases. The postoperative survival rate was studied using the operative and histologic findings.
RESULTS: Most of the patients who survived for 2 or 3 years were in the carcinoma-free surgical margins group.
CONCLUSION: The most important indication for an extended radical resection combined with portal vein resection for pancreatic cancer is the ability to obtain surgical cancer-free margins. There is no indication for an extended resection in patients in whom the surgical margins will become cancer positive if such an operation is employed.

Entities:  

Mesh:

Year:  2004        PMID: 15084973     DOI: 10.1097/00006676-200404000-00014

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  24 in total

Review 1.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Indications and techniques of extended resection for pancreatic cancer.

Authors:  Akimasa Nakao; Shin Takeda; Soichiro Inoue; Shuji Nomoto; Naohito Kanazumi; Hiroyuki Sugimoto; Tsutomu Fujii
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

3.  Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.

Authors:  N Volkan Adsay; Olca Basturk; Burcu Saka; Pelin Bagci; Denizhan Ozdemir; Serdar Balci; Juan M Sarmiento; David A Kooby; Charles Staley; Shishir K Maithel; Rhonda Everett; Jeanette D Cheng; Duangpeng Thirabanjasak; Donald W Weaver
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

4.  MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: correlation with en bloc pathological specimens and diagnostic accuracy.

Authors:  Kentaro Mochizuki; Toshifumi Gabata; Kazuto Kozaka; Yuki Hattori; Yoh Zen; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta; Osamu Matsui
Journal:  Eur Radiol       Date:  2010-02-10       Impact factor: 5.315

5.  Preoperative radiographic vascular involvement score predicts the prognosis of resected pancreatic head adenocarcinoma.

Authors:  Shunsuke Onoe; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Yasuyuki Fukami
Journal:  Langenbecks Arch Surg       Date:  2017-03-01       Impact factor: 3.445

6.  Extended lymphadenectomy in pancreatic cancer is crucial.

Authors:  Tsutomu Fujii
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

7.  Extended radical operation of pancreatic head cancer: appraisal of its clinical significance.

Authors:  De-Qing Mu; Shu-You Peng; Guo-Feng Wang
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

8.  En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.

Authors:  Hirohisa Kitagawa; Hidehiro Tajima; Hisatoshi Nakagawara; Isamu Makino; Tomoharu Miyashita; Masatoshi Shoji; Shinichi Nakanuma; Norihiro Hayashi; Hiroyuki Takamura; Tetsuo Ohta; Hiroshi Ohtake
Journal:  Mol Clin Oncol       Date:  2014-02-27

Review 9.  Pancreatic cancer: Open or minimally invasive surgery?

Authors:  Yu-Hua Zhang; Cheng-Wu Zhang; Zhi-Ming Hu; De-Fei Hong
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

10.  A patient with unresectable advanced pancreatic cancer achieving long-term survival with gemcitabine chemotherapy.

Authors:  Yoshiki Okamoto; Takashi Maeba; Keitarou Kakinoki; Keiichi Okano; Kunihiko Izuishi; Hisao Wakabayashi; Hisashi Usuki; Yasuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.